Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

174 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
EORTC protocols in prostatic cancer. An interim report.
Pavone-Macaluso M, Lund F, Mulder JH, Smith PH, De Pauw M, Sylvester R. Pavone-Macaluso M, et al. Scand J Urol Nephrol Suppl. 1980;55:163-8. Scand J Urol Nephrol Suppl. 1980. PMID: 6938020 Clinical Trial.
Adjuvant chemotherapy for superficial transitional cell bladder carcinoma: long-term results of a European Organization for Research and Treatment of Cancer randomized trial comparing doxorubicin, ethoglucid and transurethral resection alone.
Kurth K, Tunn U, Ay R, Schröder FH, Pavone-Macaluso M, Debruyne F, ten Kate F, de Pauw M, Sylvester R. Kurth K, et al. J Urol. 1997 Aug;158(2):378-84. doi: 10.1016/s0022-5347(01)64484-7. J Urol. 1997. PMID: 9224307 Clinical Trial.
EORTC protocol 30761: a randomized study of non-metastatic and metastatic prostatic cancer treated by cyproterone acetate versus diethylstilbestrol and medroxyprogesterone acetate. European Organization for Research on Treatment of Cancer Urological Group.
Pavone-Macaluso M, Schröder FH, de Voogt HJ, Viggiano G, Barasolo E, Lardennois B, de Pauw M, Sylvester R, Smith PH, Suciu S. Pavone-Macaluso M, et al. Prog Clin Biol Res. 1989;303:111-6. Prog Clin Biol Res. 1989. PMID: 2528735 Clinical Trial. No abstract available.
Cardiovascular side effects of diethylstilbestrol, cyproterone acetate, medroxyprogesterone acetate and estramustine phosphate used for the treatment of advanced prostatic cancer: results from European Organization for Research on Treatment of Cancer trials 30761 and 30762.
de Voogt HJ, Smith PH, Pavone-Macaluso M, de Pauw M, Suciu S. de Voogt HJ, et al. J Urol. 1986 Feb;135(2):303-7. doi: 10.1016/s0022-5347(17)45620-5. J Urol. 1986. PMID: 2935644 Clinical Trial.
Comparison of diethylstilbestrol, cyproterone acetate and medroxyprogesterone acetate in the treatment of advanced prostatic cancer: final analysis of a randomized phase III trial of the European Organization for Research on Treatment of Cancer Urological Group.
Pavone-Macaluso M, de Voogt HJ, Viggiano G, Barasolo E, Lardennois B, de Pauw M, Sylvester R. Pavone-Macaluso M, et al. J Urol. 1986 Sep;136(3):624-31. doi: 10.1016/s0022-5347(17)44996-2. J Urol. 1986. PMID: 2942707 Clinical Trial.
Re: Cardiovascular side effects of diethylstilbestrol, cyproterone acetate, medroxyprogesterone acetate and estramustine phosphate used for the treatment of advanced prostatic cancer: results from European Organization for Research on Treatment of Cancer Trials 30761 and 30762.
deVoogt HJ, Pavone-Macaluso M, Sylvester R, Schröder FH. deVoogt HJ, et al. J Urol. 1988 Dec;140(6):1557. doi: 10.1016/s0022-5347(17)42118-5. J Urol. 1988. PMID: 2973530 Clinical Trial. No abstract available.
174 results